Literature DB >> 21255003

Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?

Anurag K Agrawal, James H Feusner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255003     DOI: 10.1111/j.1365-2141.2010.08506.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

Review 1.  Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).

Authors:  Rachael Hough; Ajay Vora
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

2.  The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma.

Authors:  Rebecca Citrin; Kelly D Getz; Yimei Li; Yuan-Shung Huang; Joseph P Horowitz; Alix E Seif; Brian T Fisher; Richard Aplenc
Journal:  Br J Haematol       Date:  2018-04-02       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.